Aspirin: clinical trials recruiting now
18
Recruiting trials
15
Conditions studied
44
US states with sites
24
Countries
FDA drug label
- FDA-approved
- Yes. Aspirin appears in the FDA drug-label database. Marketed as Low Dose Aspirin.
- Drug class
- Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor (FDA established pharmacologic class)
- Mechanism of action
- Cyclooxygenase Inhibitors (as stated on the FDA label)
FDA-approved use
Uses for the temporary relief of minor aches and pains or as recommended by your doctor. Because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. ask your doctor about other uses for safety coated 81 mg aspirin
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — CARDINAL HEALTHCARE | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2022-01-26 |
| cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. — Safecor Health, LLC | Class II (FDA: may cause temporary or reversible harm) | Ongoing | 2024-11-11 |
| Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information. — Aurobindo Pharma USA Inc | Class I (FDA: reasonable probability of serious harm or death) | Ongoing | 2024-07-11 |
| Failed Tablet/Capsule Specification : Capsule breakage — Glenmark Pharmaceuticals Inc., USA | Class III (FDA: unlikely to cause harm) | Ongoing | 2022-06-29 |
| Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg. — Aero Healthcare | Class II (FDA: may cause temporary or reversible harm) | Ongoing | 2025-10-17 |
Phase breakdown
Early Phase 1 2
Phase 2 2
Phase 3 6
Phase 4 8
Not applicable 1
Conditions being studied
Recruiting trials involving Aspirin
- A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
- AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
- Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
- COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
- Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
- Comparison of High- Versus Low-Dose Aspirin for Pregnancy Outcomes in Women at High Risk of Preeclampsia
- Daily Aspirin Treatment After Preeclampsia
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
- LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
- Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
- Predictors of Aspirin Failure in Preeclampsia Prevention
- Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
- Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
- Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
- The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Common questions
Is Aspirin FDA-approved?
Yes, marketed as Low Dose Aspirin.
How many recruiting trials involve Aspirin?
18 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.